Lightnews — Scholar-powered news

LightNews

AIN/Sandipan Shringi

@nephrosage.bsky.social

120 followers 770 following 37 posts

AnotherIndianNephrologist @Nephrosage

Posts Media Videos Starter Packs

AIN/Sandipan Shringi @nephrosage.bsky.social · 1d

Treatment of relapsing minimal change podocytopathy
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social

AIN/Sandipan Shringi @nephrosage.bsky.social · 2d

Cardio-kidney outcomes for combined versus monotherapy with finerenone or SGLT2 inhibitors in patients with CKD
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social

AIN/Sandipan Shringi @nephrosage.bsky.social · 3d

lumasiran in primary hyperoxaluria type 1
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social

AIN/Sandipan Shringi @nephrosage.bsky.social · 6d

EKFC or CKD-EPIASR-NB2009 formula. Which equation to use?
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social

AIN/Sandipan Shringi @nephrosage.bsky.social · 6d

Dietary vitamin E and tocopherol isoform intake and the progression of CKD
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social

AIN/Sandipan Shringi @nephrosage.bsky.social · 8d

Acute post-streptococcal glomerulonephritis in children—treatment standard
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social

AIN/Sandipan Shringi @nephrosage.bsky.social · 9d

SGLT2 inhibitors in CKD: are they really effective in all patients?
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social

AIN/Sandipan Shringi @nephrosage.bsky.social · 10d

Review on Renal amyloidosis
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social

AIN/Sandipan Shringi @nephrosage.bsky.social · 13d

IgG4-RD and B cell depletion therapy
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social

AIN/Sandipan Shringi @nephrosage.bsky.social · 13d

More on IgAN
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social

Reposted by AIN/Sandipan Shringi

Hans-Joachim Anders @hjanders.bsky.social · 27d

Now open access in @NDTsocial

Anti-GBM disease - Treatment Standard

🧐 Anti-GBM and ANCA positive pts have a higher relapse risk and require maintenance immunosuppressive treatment

▶️ academic.oup.com/ndt/article/...

Reposted by AIN/Sandipan Shringi

Anthony Chang, MD @changucanspare.bsky.social · Sep 12

Kristen Tillquist, @nephrosage.bsky.social, me, and Susie Hu wrote this onconephrology topic for AJKD Core Curriculum

www.sciencedirect.com/science/arti...

The Nephrologist’s Perspective in Evaluation and Management of Localized Renal Masses: Core Curriculum 2025

The evaluation and management of renal masses, predominantly of the clear cell renal cell carcinoma subtype, have been evolving over the past several …

www.sciencedirect.com

AIN/Sandipan Shringi @nephrosage.bsky.social · Sep 10

Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: insights from the CREDENCE trial
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social

Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: insights from the CREDENCE trial

ABSTRACTBackground. Insulin is a mainstay treatment for diabetes, but its use is associated with weight gain and hypoglycaemia. Data on the effects of sodi

academic.oup.com

AIN/Sandipan Shringi @nephrosage.bsky.social · Sep 9

A predicting tool for kidney function recovery after drug-induced acute interstitial nephritis
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social

A predicting tool for kidney function recovery after drug-induced acute interstitial nephritis

ABSTRACTBackground. Drug-induced acute interstitial nephritis (DI-AIN) represents a common cause of acute kidney injury. Early withdrawal of the culprit dr

academic.oup.com

AIN/Sandipan Shringi @nephrosage.bsky.social · Sep 9

Autologous hematopoietic stem cell transplantation for non-AL amyloidosis monoclonal gammopathy of renal significance
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social

Autologous hematopoietic stem cell transplantation for non-AL amyloidosis monoclonal gammopathy of renal significance

ABSTRACTBackground. The treatment strategy for non-immunoglobulin light chain (AL) amyloidosis monoclonal gammopathy of renal significance (MGRS) remains u

academic.oup.com

AIN/Sandipan Shringi @nephrosage.bsky.social · Sep 8

Global access to management of primary hyperoxaluria: a survey on behalf of OxalEurope, G&K Working Group of the ERA and ESPN
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social

Global access to management of primary hyperoxaluria: a survey on behalf of OxalEurope, G&K Working Group of the ERA and ESPN

ABSTRACTBackground. Primary hyperoxaluria (PH) is a rare disorder with significant morbidity and mortality if left untreated. Given the rarity, global ineq

academic.oup.com

AIN/Sandipan Shringi @nephrosage.bsky.social · Sep 8

Early compensatory increase in single-kidney estimated GFR after unilateral nephrectomy is associated with a lower long-term risk of estimated GFR decline
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social

Early compensatory increase in single-kidney estimated GFR after unilateral nephrectomy is associated with a lower long-term risk of estimated GFR decline

ABSTRACTBackground and hypothesis. A more pronounced short-term increase in single-kidney GFR (ΔskGFR) has been associated with better long-term kidney fun

academic.oup.com

AIN/Sandipan Shringi @nephrosage.bsky.social · Sep 5

Treatment standard: CKD in the geriatric patient
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social

Treatment standard: CKD in the geriatric patient

ABSTRACT. The number of older people with chronic kidney disease (CKD) is increasing globally. The vast majority of these patients will die before they eve

academic.oup.com

AIN/Sandipan Shringi @nephrosage.bsky.social · Sep 5

Which agent are you using in post kidney transplant dyslipidemia? statin, ezetimibe, PCSK9 modulators or bempedoic acid?
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social

Lipid-lowering agents in solid organ transplant recipients

ABSTRACT. Although pre- and post-transplant dyslipidaemia is one of the most prevalent modifiable risk factors associated with an increased risk of major c

academic.oup.com

AIN/Sandipan Shringi @nephrosage.bsky.social · Sep 4

Acute kidney injury, acute kidney disease and chronic kidney disease: challenges and research perspectives
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social

AIN/Sandipan Shringi @nephrosage.bsky.social · Sep 4

The debate goes on: More versus less intensive blood pressure reduction and kidney function outcomes
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social

AIN/Sandipan Shringi @nephrosage.bsky.social · Sep 3

A step toward personalized medicine
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social, @Richard Glassock, @Andrew Rule, @Aleksandar Denic, @delanaye.bsky.social

AIN/Sandipan Shringi @nephrosage.bsky.social · Sep 3

Key efforts to leave those 20-30 nephrons where they belong..in the kidney! Can biopsy be prevented using PLA2R in the select few?
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social

AIN/Sandipan Shringi @nephrosage.bsky.social · Aug 21

Il take that link. Would love to hear it!

Reposted by AIN/Sandipan Shringi

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · Aug 20

Another case of assay interference and pseudo-AKI

www.kireports.org/article/S246...

From @kidneyint.bsky.social

#NephSky